KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Total Non-Current Liabilities (2016 - 2025)

Pfizer (PFE) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $5.7 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 7.57% to $5.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Dec 2025, down 7.57% year-over-year, with the annual reading at $5.7 billion for FY2025, 7.57% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $5.7 billion at Pfizer, down from $112.2 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $121.0 billion in Q3 2024, with the low at $5.2 billion in Q4 2021.
  • Average Total Non-Current Liabilities over 5 years is $70.0 billion, with a median of $89.0 billion recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities fell 16.98% in 2021, then soared 537.15% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $6.5 billion in 2021, then fell by 8.26% to $6.0 billion in 2022, then increased by 0.03% to $6.0 billion in 2023, then increased by 3.45% to $6.2 billion in 2024, then fell by 7.57% to $5.7 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $5.7 billion, $112.2 billion, and $113.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.